Critical Pharmaceuticals
HomeCompany ProfileNewsTechnologyManagement TeamPipelineEventsContact Us

Latest News

6th September 2011
  Interim Results of CP024 Nasal hGH Phase 1 Program Show Comparable Bioactivity to Injection
5th April 2011
  PolyTherics and Critical Pharmaceuticals enter drug development collaboration with TSB funding
8th March 2011
  CriticalSorb Delivery Technology Shows Excellent Local Tolerability in Long Term Preclinical Studies
Technology
 

Technology

Critical Pharmaceuticals has developed two unique drug delivery technologies:

CriticalSorb for the non-invasive nasal delivery delivery of high-value biologic products and challenging small molecule drugs.

CriticalMix for the manufacture of highly active sustained release depot products for bimonthly, monthly or even less frequent injection.

 

 
 

 

Our Process